References
- Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999;117(5):573–583
- Kass MA, Heuer DK, Higgenbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–713
- Kymes SM, Kass MA, Anderson DR, et al. Ocular Hypertension Treatment Study Group. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 2006;141(6):997–1008
- Kawasaki R, Akune Y, Hiratsukau Y, et al. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study. Ophthalmic Epidemiol 2015;22(1):4–12
- Ma Y, Ying X, Zou H, et al. Cost-utility analysis of rhegmatogenous retinal detachment surgery in Shanghai China. Ophthalmic Epidemiol 2015;22(1):13–19
- Polack S, Alavi Y, Reddi SR, et al. Utility values associated with diabetic retinopathy in Chennai, India. Ophthalmic Epidemiol 2015;22(1):20–27
- Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007;84(8):809–816
- Radhakrishnan M, Venkatesh R, Valaguru V, Frick KD. Household preferences for cataract surgery in rural India: a population-based stated preference survey. Ophthalmic Epidemiol 2015;22(1):34–42
- Galor A, Zheng DD, Arheart KL, et al. Influence of socio-demographic characteristics on eye care expenditure: data from the Medical Expenditure Panel Survey 2007. Ophthalmic Epidemiol 2015;22(1):28–33
- Griffiths UK, Bozzani F, Muleya L, Mumba M. Costs of eye care services: prospective study from a faith-based hospital in Zambia. Ophthalmic Epidemiol 2015;22(1):43–51
- Kymes SM. Is it time to move beyond the QALY in vision research? Ophthalmic Epidemiol 2014;21(2):63–65